Genuine Latisse - $49 each when you buy 2

Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store

December 31, 2009 · Posted in Daily Health News · Comment 

The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy. The company told a Food and Drug Administration advisory committee in December 2008 that it would explore that potential use of the drug.

See original here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store